Evidence map›Paper›PMID 33134774›Full record

ArticleResearch and practice in thrombosis and haemostasis2020

COVID-19 pandemic perspectives: A scientific silver lining?

Dre'Von A Dobson, Alisa S Wolberg

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Impact factor to discovery: The future of thrombosis and hemostasis research.Research and practice in thrombosis and haemostasis · 2022
    Article
  2. Article
  3. Goodbye 2020, hello to our future.Research and practice in thrombosis and haemostasis · 2021
    Article
  4. COVID-19 pandemic perspectives: A scientific silver lining?Research and practice in thrombosis and haemostasis · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dre'Von A DobsonDepartment of Pathology and Laboratory Medicine and UNC Blood Research Center University of North Carolina Chapel Hill NC USA.ORCID https://orcid.org/0000-0001-5123-5473
Alisa S WolbergDepartment of Pathology and Laboratory Medicine and UNC Blood Research Center University of North Carolina Chapel Hill NC USA.ORCID https://orcid.org/0000-0002-2845-2303

Funding

Using genomics and functional biology to understand fibrinogen and its effect on thrombotic and atherosclerotic outcomesR01HL141291 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Alanna C Morrison, Alisa S. Wolberg · 2019 to 2026
$4.6M
Fibrinogen and Factor XIII in Venous ThrombosisR01HL126974 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alisa S. Wolberg · 2016 to 2026
$4.4M
NHLBI NIH HHS R01 HL126974NHLBI NIH HHS R01 HL141291
6 · The paper itself

Abstract

Accounts of the numerous negative effects caused by COVID-19 are pervasive, but few perspectives have identified any positive impacts of this massive societal shift. This forum examines potentially positive changes that have occurred within the scientific community amid the chaotic pandemic. Among these positives are the formation of virtual supergroups and an interdisciplinary brain trust. In forcing scientists away from their lab benches, COVID-19 has created time and space for more conversations about science and experimental design. Being away from the lab in this time of social unrest has also given scientists time to directly address institutional racism and its suppression of diversity in science. Although COVID-19 has been an unforeseen disaster of epic proportions, some of the resulting changes in our scientific community should remain in place after the pandemic is over. By leveraging these small wins, we will undoubtedly return to our laboratories stronger, smarter, and more efficient.

Indexed as

COVID‐19interdisciplinary researchmentorsmotivationpandemicthrombosis

Identifiers

PMID33134774
PMCPMC7590274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.